Literature DB >> 20047110

Innate immune dysfunction in acute and chronic liver disease.

Bettina Leber1, Ursula Mayrhauser, Michael Rybczynski, Vanessa Stadlbauer.   

Abstract

Liver cirrhosis is a common disease causing great public-health concern because of the frequent complications requiring hospital care. Acute liver failure is also prone to several complications but is rare. One of the main complications for both acute and chronic liver diseases is infection, which regularly causes decompensation of cirrhosis, possibly leading to organ failure and death. This review focuses on innate immune function in cirrhosis, acute-on-chronic liver failure and acute liver failure. The known defects of Kupffer cells, neutrophils and monocytes are discussed, together with the pathophysiological importance of gut permeability, portal hypertension and intrinsic cellular defects, and the role of endotoxin, albumin, lipoproteins and toll-like receptors. Based on these different pathomechanisms, the available information on therapeutic strategies is presented. Antibiotic and probiotic treatment, nutritional support, artificial liver support, and experimental strategies such as inhibition of toll-like receptors and use of albumin and colony-stimulating factors are highlighted.

Entities:  

Mesh:

Year:  2009        PMID: 20047110     DOI: 10.1007/s00508-009-1288-2

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  147 in total

Review 1.  Acute-on-chronic liver failure: pathophysiological basis of therapeutic options.

Authors:  Rajiv Jalan; Roger Williams
Journal:  Blood Purif       Date:  2002       Impact factor: 2.614

2.  CRYSTALLIZATION OF THE MERCURY DIMERS OF HUMAN AND BOVINE MERCAPTALBUMIN.

Authors:  W L HUGHES; H M DINTZIS
Journal:  J Biol Chem       Date:  1964-03       Impact factor: 5.157

3.  The lipoprotein composition of plasma and ascitic fluid in liver cirrhosis.

Authors:  S Zambon; R Orlando; G Sartore; A Bassi; E Manzato; G Crepaldi
Journal:  Eur J Clin Invest       Date:  1995-03       Impact factor: 4.686

4.  Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis.

Authors:  N K Ganguly; J G Kingham; B Lloyd; R S Lloyd; C P Price; D R Triger; R Wright
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

5.  LPS-induced imbalanced expression of hepatic vascular stress genes in cirrhosis: possible mechanism of increased susceptibility to endotoxemia.

Authors:  Rajiv Baveja; Steve Keller; Yukihiro Yokoyama; Natalie Sonin; Mark G Clemens; Jian X Zhang
Journal:  Shock       Date:  2002-04       Impact factor: 3.454

6.  Neutrophil activation in chronic liver disease.

Authors:  A J Stanley; I R MacGregor; J F Dillon; I A Bouchier; P C Hayes
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-02       Impact factor: 2.566

7.  Hepatic encephalopathy: a review of its pathophysiology and treatment.

Authors:  Nader Dbouk; Brendan M McGuire
Journal:  Curr Treat Options Gastroenterol       Date:  2006

8.  Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease.

Authors:  Carmen Fiuza; Magdalena Salcedo; Gerardo Clemente; Jose M Tellado
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

9.  Haemostatic and immunological sequelae of portacaval shunt in rats.

Authors:  S C Robson; K Jaskiewicz; G Engelbrecht; D Kahn; R Hickman; R E Kirsch
Journal:  Liver       Date:  1995-12

10.  Phagocytosis and production of reactive oxygen species by peripheral blood phagocytes in patients with different stages of alcohol-induced liver disease: effect of acute exposure to low ethanol concentrations.

Authors:  Alexandr Parlesak; Christian Schäfer; Sonja Barbara Paulus; Susanne Hammes; Jens Peter Diedrich; Christiane Bode
Journal:  Alcohol Clin Exp Res       Date:  2003-03       Impact factor: 3.455

View more
  18 in total

Review 1.  Hypoxic hepatitis - epidemiology, pathophysiology and clinical management.

Authors:  Valentin Fuhrmann; Bernhard Jäger; Anna Zubkova; Andreas Drolz
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

2.  Hemophagocytic Lymphohistiocytosis (HLH) in Children Presenting as Liver Disease.

Authors:  Nomisha Amin; Ira Shah; Sushmita Bhatnagar
Journal:  J Clin Exp Hepatol       Date:  2013-07-02

3.  Serum Toll-Like Receptor-2, Toll-Like Receptor-4 Levels in Patients with HBeAg-Negative Chronic Viral Hepatitis B.

Authors:  Erdem Akbal; Erdem Koçak; Seyfettin Köklü; Bilal Ergül; Ömer Akyürek; Fatma Meriç Yılmaz
Journal:  Viral Immunol       Date:  2017-04-17       Impact factor: 2.257

4.  HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women.

Authors:  Jason T Blackard; Jeffrey A Welge; Lynn E Taylor; Kenneth H Mayer; Robert S Klein; David D Celentano; Denise J Jamieson; Lytt Gardner; Kenneth E Sherman
Journal:  Clin Infect Dis       Date:  2011-01-19       Impact factor: 9.079

Review 5.  Immune dysfunction in cirrhosis.

Authors:  Nora Sipeki; Peter Antal-Szalmas; Peter L Lakatos; Maria Papp
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 6.  Bench-to-beside review: acute-on-chronic liver failure - linking the gut, liver and systemic circulation.

Authors:  Len Verbeke; Frederik Nevens; Wim Laleman
Journal:  Crit Care       Date:  2011-10-25       Impact factor: 9.097

7.  Anti-inflammatory and anti-fibrotic profile of fish oil emulsions used in parenteral nutrition-associated liver disease.

Authors:  Alfonso Pastor-Clerigues; Ezequiel Marti-Bonmati; Javier Milara; Patricia Almudever; Julio Cortijo
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

8.  Increased occurrence of native septic arthritis in adult cirrhotic patients: a population-based three-year follow-up study in Taiwan.

Authors:  Tsung-Hsing Hung; Min-Hong Hsieh; Chorng-Jang Lay; Chih-Chun Tsai; Chen-Chi Tsai
Journal:  Prz Gastroenterol       Date:  2014-12-30

9.  Long-term mortality due to infection associated with elevated liver enzymes: a population-based cohort study.

Authors:  Tak Kyu Oh; Eun Sun Jang; In-Ae Song
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

10.  Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study.

Authors:  Rajiv Jalan; Vanessa Stadlbauer; Sambit Sen; Lisa Cheshire; Yu-Mei Chang; Rajeshwar P Mookerjee
Journal:  Crit Care       Date:  2012-11-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.